Chronic Lymphocytic Leukemia Therapeutics Market 2027 By Cancer Type, Drug Type, Route of Administration, Distribution Channel and Geography | The Insight Partners

Chronic Lymphocytic Leukemia Therapeutics Market to 2027 - Global Analysis and Forecasts By Cancer Type (B-cell chronic lymphocytic leukemia, T-cell chronic lymphocytic leukemia, natural killer chronic lymphocytic leukemia); Drug Type (Chemotherapy Drugs, Targeted Therapy); Route of Administration (Intravenous Route, Subcutaneous Route, Oral Route, Intramuscular Route, Intrathecal Route); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Report Code: TIPRE00006726 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Chronic Lymphocytic Leukemia (CLL) is hematological malignancy occurred due to unnecessary proliferation of irregular white blood cells. CLL primarily affects the B-cell lymphocytes which are involved in the development of antibodies to fight against contaminations and foreign antigens. The several symptoms of the disease include, fatigue, swelling of the lymph nodes, fever, infection, pain beneath the ribs, and weight loss. CLL is hardly seen in children and people below 40 years of age, it is more dominant in geriatric population.


MARKET DYNAMICS

Chronic lymphocytic leukemia therapeutics market is anticipated to grow in the forecast period owing to driving factors such as rising incidences of leukemia coupled with developed diagnosis for CLL, growing geriatric population, and surge in disposable income, and increasing awareness about CLL. Moreover, advanced therapy described by FDA, discovery of some pipeline drugs, continuous research and development are also offering opportunities in the market growth during the forecast period.

MARKET SCOPE

The "Global Chronic Lymphocytic Leukemia Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of chronic lymphocytic leukemia therapeutics market with detailed market segmentation by cancer type, drug type, route of administration, and distribution channel, and geography. The global chronic lymphocytic leukemia therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading chronic lymphocytic leukemia therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global chronic lymphocytic leukemia therapeutics market is segmented on the basis of cancer type, drug type, route of administration, and distribution channel. Based on cancer type, the market is segmented as B-cell chronic lymphocytic leukemia, T-cell chronic lymphocytic leukemia, and natural killer chronic lymphocytic leukemia. Based on drug type, the market is segmented as chemotherapy drugs and targeted therapy. On the basis of route of administration, the global chronic lymphocytic leukemia therapeutics market is segmented into intravenous route, subcutaneous route, oral route, intramuscular route, and intrathecal route. On the basis of distribution channel, the global chronic lymphocytic leukemia therapeutics market is divided into hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global chronic lymphocytic leukemia therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chronic lymphocytic leukemia therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting chronic lymphocytic leukemia therapeutics market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chronic lymphocytic leukemia therapeutics market in these regions.


MARKET PLAYERS


The report covers key developments in the chronic lymphocytic leukemia therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from chronic lymphocytic leukemia therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for chronic lymphocytic leukemia therapeutics in the global market. Below mentioned is the list of few companies engaged in the chronic lymphocytic leukemia therapeutics market.

The report also includes the profiles of key chronic lymphocytic leukemia therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  GlaxoSmithKline plc.
  •  Genentech, Inc.
  •  Biogen Idec
  •  Novartis AG
  •  F. Hoffmann-La Roche AG
  •  Genzyme Corporation
  •  Celgene Corporation
  •  Teva Pharmaceutical Industries Ltd.
  •  AstraZeneca
  •  XEME Biopharma

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Chronic Lymphocytic Leukemia Therapeutics Market - By Cancer Type
1.3.2 Chronic Lymphocytic Leukemia Therapeutics Market - By Drug Type
1.3.3 Chronic Lymphocytic Leukemia Therapeutics Market - By Route of Administration
1.3.4 Chronic Lymphocytic Leukemia Therapeutics Market - By Distribution Channel
1.3.5 Chronic Lymphocytic Leukemia Therapeutics Market - By Region
1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis

5. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS

6.1. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - CANCER TYPE
7.1. OVERVIEW
7.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
7.3. B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
7.3.1. Overview
7.3.2. B-cell Chronic Lymphocytic Leukemia Market Forecast and Analysis
7.4. T-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
7.4.1. Overview
7.4.2. T-cell Chronic Lymphocytic Leukemia Market Forecast and Analysis
7.5. NATURAL KILLER CHRONIC LYMPHOCYTIC LEUKEMIA
7.5.1. Overview
7.5.2. Natural Killer Chronic Lymphocytic Leukemia Market Forecast and Analysis

8. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE

8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. CHEMOTHERAPY DRUGS
8.3.1. Overview
8.3.2. Chemotherapy Drugs Market Forecast and Analysis
8.4. TARGETED THERAPY
8.4.1. Overview
8.4.2. Targeted Therapy Market Forecast and Analysis

9. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION

9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. INTRAVENOUS ROUTE
9.3.1. Overview
9.3.2. Intravenous Route Market Forecast and Analysis
9.4. SUBCUTANEOUS ROUTE
9.4.1. Overview
9.4.2. Subcutaneous Route Market Forecast and Analysis
9.5. ORAL ROUTE
9.5.1. Overview
9.5.2. Oral Route Market Forecast and Analysis
9.6. INTRAMUSCULAR ROUTE
9.6.1. Overview
9.6.2. Intramuscular Route Market Forecast and Analysis
9.7. INTRATHECAL ROUTE
9.7.1. Overview
9.7.2. Intrathecal Route Market Forecast and Analysis

10. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL

10.1. OVERVIEW
10.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL PHARMACIES
10.3.1. Overview
10.3.2. Hospital Pharmacies Market Forecast and Analysis
10.4. RETAIL PHARMACIES
10.4.1. Overview
10.4.2. Retail Pharmacies Market Forecast and Analysis
10.5. ONLINE PHARMACIES
10.5.1. Overview
10.5.2. Online Pharmacies Market Forecast and Analysis

11. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

11.1. NORTH AMERICA
11.1.1 North America Chronic Lymphocytic Leukemia Therapeutics Market Overview
11.1.2 North America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis
11.1.3 North America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Cancer Type
11.1.4 North America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Drug Type
11.1.5 North America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Route of Administration
11.1.6 North America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.1.7 North America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Countries
11.1.7.1 United States Chronic Lymphocytic Leukemia Therapeutics Market
11.1.7.1.1 United States Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.1.7.1.2 United States Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.1.7.1.3 United States Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.1.7.1.4 United States Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.1.7.2 Canada Chronic Lymphocytic Leukemia Therapeutics Market
11.1.7.2.1 Canada Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.1.7.2.2 Canada Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.1.7.2.3 Canada Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.1.7.2.4 Canada Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.1.7.3 Mexico Chronic Lymphocytic Leukemia Therapeutics Market
11.1.7.3.1 Mexico Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.1.7.3.2 Mexico Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.1.7.3.3 Mexico Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.1.7.3.4 Mexico Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.2. EUROPE
11.2.1 Europe Chronic Lymphocytic Leukemia Therapeutics Market Overview
11.2.2 Europe Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis
11.2.3 Europe Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Cancer Type
11.2.4 Europe Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Drug Type
11.2.5 Europe Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Route of Administration
11.2.6 Europe Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.2.7 Europe Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Chronic Lymphocytic Leukemia Therapeutics Market
11.2.7.1.1 Germany Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.2.7.1.2 Germany Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.2.7.1.3 Germany Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.2.7.1.4 Germany Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.2.7.2 France Chronic Lymphocytic Leukemia Therapeutics Market
11.2.7.2.1 France Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.2.7.2.2 France Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.2.7.2.3 France Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.2.7.2.4 France Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.2.7.3 Italy Chronic Lymphocytic Leukemia Therapeutics Market
11.2.7.3.1 Italy Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.2.7.3.2 Italy Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.2.7.3.3 Italy Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.2.7.3.4 Italy Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.2.7.4 Spain Chronic Lymphocytic Leukemia Therapeutics Market
11.2.7.4.1 Spain Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.2.7.4.2 Spain Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.2.7.4.3 Spain Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.2.7.4.4 Spain Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.2.7.5 United Kingdom Chronic Lymphocytic Leukemia Therapeutics Market
11.2.7.5.1 United Kingdom Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.2.7.5.2 United Kingdom Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.2.7.5.3 United Kingdom Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.2.7.5.4 United Kingdom Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Chronic Lymphocytic Leukemia Therapeutics Market Overview
11.3.2 Asia-Pacific Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis
11.3.3 Asia-Pacific Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Cancer Type
11.3.4 Asia-Pacific Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Drug Type
11.3.5 Asia-Pacific Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Route of Administration
11.3.6 Asia-Pacific Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.3.7 Asia-Pacific Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Chronic Lymphocytic Leukemia Therapeutics Market
11.3.7.1.1 Australia Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.3.7.1.2 Australia Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.3.7.1.3 Australia Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.3.7.1.4 Australia Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.3.7.2 China Chronic Lymphocytic Leukemia Therapeutics Market
11.3.7.2.1 China Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.3.7.2.2 China Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.3.7.2.3 China Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.3.7.2.4 China Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.3.7.3 India Chronic Lymphocytic Leukemia Therapeutics Market
11.3.7.3.1 India Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.3.7.3.2 India Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.3.7.3.3 India Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.3.7.3.4 India Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.3.7.4 Japan Chronic Lymphocytic Leukemia Therapeutics Market
11.3.7.4.1 Japan Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.3.7.4.2 Japan Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.3.7.4.3 Japan Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.3.7.4.4 Japan Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.3.7.5 South Korea Chronic Lymphocytic Leukemia Therapeutics Market
11.3.7.5.1 South Korea Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.3.7.5.2 South Korea Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.3.7.5.3 South Korea Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.3.7.5.4 South Korea Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Chronic Lymphocytic Leukemia Therapeutics Market Overview
11.4.2 Middle East and Africa Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis
11.4.3 Middle East and Africa Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Cancer Type
11.4.4 Middle East and Africa Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Drug Type
11.4.5 Middle East and Africa Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Route of Administration
11.4.6 Middle East and Africa Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.4.7 Middle East and Africa Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Chronic Lymphocytic Leukemia Therapeutics Market
11.4.7.1.1 South Africa Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.4.7.1.2 South Africa Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.4.7.1.3 South Africa Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.4.7.1.4 South Africa Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.4.7.2 Saudi Arabia Chronic Lymphocytic Leukemia Therapeutics Market
11.4.7.2.1 Saudi Arabia Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.4.7.2.2 Saudi Arabia Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.4.7.2.3 Saudi Arabia Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.4.7.2.4 Saudi Arabia Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.4.7.3 U.A.E Chronic Lymphocytic Leukemia Therapeutics Market
11.4.7.3.1 U.A.E Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.4.7.3.2 U.A.E Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.4.7.3.3 U.A.E Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.4.7.3.4 U.A.E Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Chronic Lymphocytic Leukemia Therapeutics Market Overview
11.5.2 South and Central America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis
11.5.3 South and Central America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Cancer Type
11.5.4 South and Central America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Drug Type
11.5.5 South and Central America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Route of Administration
11.5.6 South and Central America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Distribution Channel
11.5.7 South and Central America Chronic Lymphocytic Leukemia Therapeutics Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Chronic Lymphocytic Leukemia Therapeutics Market
11.5.7.1.1 Brazil Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.5.7.1.2 Brazil Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.5.7.1.3 Brazil Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.5.7.1.4 Brazil Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel
11.5.7.2 Argentina Chronic Lymphocytic Leukemia Therapeutics Market
11.5.7.2.1 Argentina Chronic Lymphocytic Leukemia Therapeutics Market by Cancer Type
11.5.7.2.2 Argentina Chronic Lymphocytic Leukemia Therapeutics Market by Drug Type
11.5.7.2.3 Argentina Chronic Lymphocytic Leukemia Therapeutics Market by Route of Administration
11.5.7.2.4 Argentina Chronic Lymphocytic Leukemia Therapeutics Market by Distribution Channel

12. INDUSTRY LANDSCAPE

12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13. CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET, KEY COMPANY PROFILES

13.1. GLAXOSMITHKLINE PLC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GENENTECH, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOGEN IDEC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVARTIS AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. F. HOFFMANN-LA ROCHE AG
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. GENZYME CORPORATION
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CELGENE CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. ASTRAZENECA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. XEME BIOPHARMA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments

14. APPENDIX

14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline plc.
2. Genentech, Inc.
3. Biogen Idec
4. Novartis AG
5. F. Hoffmann-La Roche AG
6. Genzyme Corporation
7. Celgene Corporation
8. Teva Pharmaceutical Industries Ltd.
9. AstraZeneca
10. XEME Biopharma